Protein detail

RHG09

Rho GTPase-activating protein 9 (Rho-type GTPase-activating protein 9)

Entry name
RHG09
UniProt ID
EVMP score
0.38
Frequency
2
Transmembrane count
Protein classification
EVMP score: annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information
Protein Names
Rho GTPase-activating protein 9 (Rho-type GTPase-activating protein 9)
Protein Function
Predicted intracellular proteins
Entrez Gene Symbol
Frequency
2
EVMP Score
0.38
Fluorescence & Localization
Tissue SpecificliverCell SpecificAdrenal medulla cells
Function & Pathway
Relations & Evidence

Enzyme-Mediated Modification

0 records.

Ligand-Receptor Signaling

5 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
ecmecmMatrixDBYesNoNoNoNo
ecmecmOmniPathYesNoNoNoNo
intracellularintracellularComPPINoNoNoNoNo
intracellularintracellularGO_IntercellNoNoNoNoNo
intracellularintracellularOmniPathNoNoNoNoNo

Regulatory Interaction Network

1 record.

Source Protein SymbolSource UniProt IDTarget Protein SymbolTarget UniProt IDIs DirectedIs StimulationIs InhibitionDatabaseReferences
RHG09Q9BRR9RAC1P63000YesNoYesWangSIGNORSIGNOR:32203420

Protein Complex Composition

0 records.

Isolation & Detection Technology

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationDensity Gradient CentrifugationUltrafiltration / Tangential Flow FiltrationSize Exclusion ChromatographyImmunoaffinity CaptureMass spectrometryWestern blottingFlow cytometry9315085003481790632795414289865853060870038321535400983464120109030760538
Sequence, Structure & Domains

Sequences

Length
750
Mass
83,260
Sequence
MLSSRWWPSSWGILGLGPRSPPRGSQLCALYAFTYTGADGQQVSLAEGDRFLLLRKTNSDWWLARRLEAPSTSRPIFVPAAYMIEESIPSQSPTTVIPGQLLWTPGPKLFHGSLEELSQALPSRAQASSEQPPPLPRKMCRSVSTDNLSPSLLKPFQEGPSGRSLSQEDLPSEASASTAGPQPLMSEPPVYCNLVDLRRCPRSPPPGPACPLLQRLDAWEQHLDPNSGRCFYINSLTGCKSWKPPRRSRSETNPGSMEGTQTLKRNNDVLQPQAKGFRSDTGTPEPLDPQGSLSLSQRTSQLDPPALQAPRPLPQLLDDPHEVEKSGLLNMTKIAQGGRKLRKNWGPSWVVLTGNSLVFYREPPPTAPSSGWGPAGSRPESSVDLRGAALAHGRHLSSRRNVLHIRTIPGHEFLLQSDHETELRAWHRALRTVIERLVRWVEARREAPTGRDQGSGDRENPLELRLSGSGPAELSAGEDEEEESELVSKPLLRLSSRRSSIRGPEGTEQNRVRNKLKRLIAKRPPLQSLQERGLLRDQVFGCQLESLCQREGDTVPSFLRLCIAAVDKRGLDVDGIYRVSGNLAVVQKLRFLVDRERAVTSDGRYVFPEQPGQEGRLDLDSTEWDDIHVVTGALKLFLRELPQPLVPPLLLPHFRAALALSESEQCLSQIQELIGSMPKPNHDTLRYLLEHLCRVIAHSDKNRMTPHNLGIVFGPTLFRPEQETSDPAAHALYPGQLVQLMLTNFTSLFP
Alternative Products
Event=Alternative splicing; Named isoforms=5; Name=1; IsoId=Q9BRR9-1; Sequence=Displayed; Name=2; IsoId=Q9BRR9-2; Sequence=VSP_010325; Name=3; IsoId=Q9BRR9-3; Sequence=VSP_010340; Name=4; IsoId=Q9BRR9-4; Sequence=VSP_010340, VSP_010325; Name=5; IsoId=Q9BRR9-5; Sequence=VSP_010325, VSP_046391
Alternative Sequence
1..184; Missing (in isoform 3 and isoform 4); 438..456; Missing (in isoform 2, isoform 4 and isoform 5); 659..750; ALSESEQCLSQIQELIGSMPKPNHDTLRYLLEHLCRVIAHSDKNRMTPHNLGIVFGPTLFRPEQETSDPAAHALYPGQLVQLMLTNFTSLFP -> G (in isoform 5)

3D Structural Models

Turn
394..396
Helix
368..370; 420..439
Beta Strand
322..336; 346..361; 380..384; 389..392; 398..406; 412..416
3D Structure
X-ray crystallography (3)

Domain & Motif Annotations

Compositional Bias
163..180; Polar residues; 251..270; Polar residues; 291..300; Polar residues; 301..317; Low complexity; 446..462; Basic and acidic residues; 476..485; Acidic residues
Domain (CC)
A region including the PH domain and partially overlapping with the Rho-GAP domain mediates interaction with phosphoinositides.
Domain (FT)
22..88; SH3; 213..247; WW; 322..435; PH; 542..749; Rho-GAP
Region
120..187; Disordered; 242..319; Disordered; 342..345; Lipid binding; 397..399; Lipid binding; 432..669; Lipid binding; 446..488; Disordered
Clinical Relevance
Interaction Protein
ENSG00000177885
Interaction Count
1
Interaction Dataset
intact_biogrid